5-hydroxy-2,3-dimethyl-benzoic acid | 5628-57-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 5-hydroxy-2,3-dimethyl-benzoic acid
• 英文别名: 5-Hydroxy-2,3-dimethyl-benzoesaeure；2,3-Dimethyl-5-hydroxy-benzoesaeure；2.3-Dimethyl-5-hydroxy-benzoesaeure；5-Hydroxy-2,3-dimethylbenzoic acid
• CAS: 5628-57-9
• 化学式: C₉H₁₀O₃
• 分子量: 166.177
• InChiKey: TUGKHWASTFDHMB-UHFFFAOYSA-N

物化性质

• 沸点：
  358.9±30.0 °C(Predicted)
• 密度：
  1.249±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2,3-dimethyl-5-nitrobenzonitrile 在 palladium on activated charcoal 盐酸 、 氢氧化钾 、 磷酸 、 氢气 作用下， 以 甲醇 、 乙醚 为溶剂， 生成 5-hydroxy-2,3-dimethyl-benzoic acid
  参考文献：
  名称：

  REACTION OF ANHYDROSEPEDONIN WITH ALKALI SYNTHESIS OF A DEGRADATION PRODUCT AND SOME RELATED DIMETHYLHYDROXYBENZOIC ACIDS

  摘要：

  从无水石蕈酮与碱反应中分离出两种产物，并鉴定为3-羟基-5-甲基苯甲酸和3,4-二甲基-5-羟基苯甲酸。后一化合物的结构通过明确的合成得到确认。在这项工作中，还制备了从o-二甲苯衍生的其余o-和m-羟基苯甲酸。

  DOI：

  10.1139/v64-010

文献信息

• Organic Compounds
  申请人：Ehara Takeru

  公开号：US20090192148A1

  公开（公告）日：2009-07-30

  The invention relates to 3,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,5-substituted piperidine compound, a method for the manufacture of a 3,5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis. The compounds have the formula I′ wherein R1, R2, T, R3 and R4 areas defined in the specification.

  本发明涉及3,5-取代哌啶化合物，这些化合物用于诊断和治疗温血动物，特别是用于治疗依赖肾素活性的疾病（=失调）；该类化合物用于制备治疗依赖肾素活性疾病的制剂；该类化合物用于治疗依赖肾素活性的疾病；包括3,5-取代哌啶化合物的制药配方和/或包括给予3,5-取代哌啶化合物的治疗方法，以及制造3,5-取代哌啶化合物的新型中间体和部分合成步骤。该化合物的式子为I'，其中R1、R2、T、R3和R4在规范中有定义。
• 3 , 5-substitued piperidine compounds as renin inhibitors
  申请人：Novartis AG

  公开号：EP2420491A1

  公开（公告）日：2012-02-22

  The invention relates to 3,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (= disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,5-substituted piperidine compound, a method for the manufacture of a 3, 5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis. The compounds (which can also be present as salts) have the formula I' wherein R1, R2, T, R3, R4, R7 and R8 are as defined in the specification and R6 is OH.

  本发明涉及3,5-取代的哌啶化合物，这些化合物用于温血动物的诊断和治疗，特别是用于治疗依赖于肾素活性的疾病（=紊乱）；使用该类化合物制备药物制剂，用于治疗依赖于肾素活性的疾病；该类化合物在治疗依赖于肾素活性的疾病中的用途；包含 3,5-取代的哌啶化合物的药物制剂，和/或包括施用 3,5-取代的哌啶化合物的治疗方法，3,5-取代的哌啶化合物的制造方法，及其合成的新型中间体和部分步骤。 这些化合物（也可以以盐的形式存在）具有式 I' 其中 R1、R2、T、R3、R4、R7 和 R8 如说明书中所定义，R6 为 OH。
• Plieninger; Suehiro, Chemische Berichte, 1956, vol. 89, p. 2789,2793
  作者：Plieninger、Suehiro

  DOI：——

  日期：——
• PROCESS FOR PRODUCING CARBON
  申请人：Sumitomo Chemical Company, Limited

  公开号：EP2231515A2

  公开（公告）日：2010-09-29
• US8129411B2
  申请人：——

  公开号：US8129411B2

  公开（公告）日：2012-03-06